{"id":"https://openalex.org/W2162633394","doi":"https://doi.org/10.1093/ndt/gfm259","title":"Renal side effects of anti-VEGF therapy in man: a new test system","display_name":"Renal side effects of anti-VEGF therapy in man: a new test system","alternate_titles":[],"publication_year":2007,"publication_date":"2007-07-07","ids":{"openalex":"https://openalex.org/W2162633394","doi":"https://doi.org/10.1093/ndt/gfm259","mag":"2162633394","pmid":"https://pubmed.ncbi.nlm.nih.gov/17616538"},"language":"en","primary_location":{"id":"doi:10.1093/ndt/gfm259","doi":"https://doi.org/10.1093/ndt/gfm259","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ndt/gfm259","pdf_url":null,"source":{"id":"https://openalex.org/S186113128","display_name":"Nephrology Dialysis Transplantation","issn_l":"0931-0509","issn":["0931-0509","1460-2385"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephrology Dialysis Transplantation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2162633394"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065533886","display_name":"Tammo Ostendorf","orcid":"https://orcid.org/0000-0003-2889-5371","observed_orcids":["https://orcid.org/0000-0003-2889-5371"]},"institutions":[{"id":"https://openalex.org/I4210120689","display_name":"Universit\u00e4tsklinikum Aachen","ror":"https://ror.org/02gm5zw39","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210120689"]},{"id":"https://openalex.org/I4210123377","display_name":"AZ Sint-Jan","ror":"https://ror.org/030h1vb90","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210123377"]},{"id":"https://openalex.org/I887968799","display_name":"RWTH Aachen University","ror":"https://ror.org/04xfq0f34","country_code":"DE","type":"education","lineage":["https://openalex.org/I887968799"]}],"countries":["BE","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. Ostendorf","raw_affiliation_strings":["Division of Nephrology, University Hospital Aachen, Pauwelsstr. 30, D-52057 Aachen, Germany. tostendorf@ukaachen.de","Division of Nephrology, RWTH University of Aachen, Aachen, Germany and 2The Renal Unit, AZ Sint-Jan AV, Brugge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, University Hospital Aachen, Pauwelsstr. 30, D-52057 Aachen, Germany. tostendorf@ukaachen.de","institution_ids":["https://openalex.org/I4210120689"]},{"raw_affiliation_string":"Division of Nephrology, RWTH University of Aachen, Aachen, Germany and 2The Renal Unit, AZ Sint-Jan AV, Brugge, Belgium","institution_ids":["https://openalex.org/I4210123377","https://openalex.org/I887968799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019721633","display_name":"An S. De Vriese","orcid":"https://orcid.org/0000-0002-9596-8529","observed_orcids":["https://orcid.org/0000-0002-9596-8529"]},"institutions":[{"id":"https://openalex.org/I4210123377","display_name":"AZ Sint-Jan","ror":"https://ror.org/030h1vb90","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210123377"]},{"id":"https://openalex.org/I887968799","display_name":"RWTH Aachen University","ror":"https://ror.org/04xfq0f34","country_code":"DE","type":"education","lineage":["https://openalex.org/I887968799"]}],"countries":["BE","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. S. De Vriese","raw_affiliation_strings":["Division of Nephrology, RWTH University of Aachen, Aachen, Germany and 2 The Renal Unit, AZ Sint-Jan AV, Brugge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, RWTH University of Aachen, Aachen, Germany and 2 The Renal Unit, AZ Sint-Jan AV, Brugge, Belgium","institution_ids":["https://openalex.org/I4210123377","https://openalex.org/I887968799"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107960647","display_name":"J\u00fcrgen Floege","orcid":"https://orcid.org/0000-0001-7102-6150","observed_orcids":["https://orcid.org/0000-0001-7102-6150"]},"institutions":[{"id":"https://openalex.org/I4210123377","display_name":"AZ Sint-Jan","ror":"https://ror.org/030h1vb90","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210123377"]},{"id":"https://openalex.org/I887968799","display_name":"RWTH Aachen University","ror":"https://ror.org/04xfq0f34","country_code":"DE","type":"education","lineage":["https://openalex.org/I887968799"]}],"countries":["BE","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Floege","raw_affiliation_strings":["Division of Nephrology, RWTH University of Aachen, Aachen, Germany and 2 The Renal Unit, AZ Sint-Jan AV, Brugge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, RWTH University of Aachen, Aachen, Germany and 2 The Renal Unit, AZ Sint-Jan AV, Brugge, Belgium","institution_ids":["https://openalex.org/I4210123377","https://openalex.org/I887968799"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3474,"currency":"EUR","value_usd":3926},"apc_paid":null,"fwci":0.6777,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.61220397,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"22","issue":"10","first_page":"2778","last_page":"2780"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9290000200271606},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.8019999861717224},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9520000219345093},{"id":"https://openalex.org/keywords/vegf-a","display_name":"VEGF-A","score":0.7009999752044678},{"id":"https://openalex.org/keywords/antibody-affinity","display_name":"antibody affinity","score":0.5239999890327454},{"id":"https://openalex.org/keywords/glomerulosclerosis","display_name":"glomerulosclerosis","score":0.906000018119812},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.6769999861717224},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.703000009059906},{"id":"https://openalex.org/keywords/preclinical-safety-evaluation","display_name":"preclinical safety","score":0.7630000114440918},{"id":"https://openalex.org/keywords/vegf-receptor-antagonist","display_name":"VEGF receptor antagonist","score":0.6600000262260437},{"id":"https://openalex.org/keywords/podocyte-injury","display_name":"podocyte injury","score":0.8529999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9546688199043274},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.5669206976890564},{"id":"https://openalex.org/C2777267654","wikidata":"https://www.wikidata.org/wiki/Q3519023","display_name":"Test (biology)","level":2,"score":0.48270559310913086},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.42055800557136536},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.37461283802986145},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34575629234313965},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006579","descriptor_name":"Heterozygote","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D017434","descriptor_name":"Protein Structure, Tertiary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/ndt/gfm259","doi":"https://doi.org/10.1093/ndt/gfm259","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ndt/gfm259","pdf_url":null,"source":{"id":"https://openalex.org/S186113128","display_name":"Nephrology Dialysis Transplantation","issn_l":"0931-0509","issn":["0931-0509","1460-2385"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephrology Dialysis Transplantation","raw_type":"journal-article"},{"id":"pmid:17616538","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17616538","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","raw_type":"Journal Article"},{"id":"pmh:oai:publications.rwth-aachen.de:163543","doi":null,"is_oa":false,"landing_page_url":"https://publications.rwth-aachen.de/search?p=id:%22RWTH-CONV-041498%22","pdf_url":null,"source":{"id":"https://openalex.org/S4306401362","display_name":"RWTH Publications (RWTH Aachen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I887968799","host_organization_name":"RWTH Aachen University","host_organization_lineage":["https://openalex.org/I887968799"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephrology, dialysis, transplantation : NDT 22(10), 2778-2780 (2007). doi:10.1093/ndt/gfm259","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.590.1480","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.590.1480","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://ndt.oxfordjournals.org/content/22/10/2778.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1992270161","https://openalex.org/W1999647741","https://openalex.org/W2020511056","https://openalex.org/W2029313468","https://openalex.org/W2032429643","https://openalex.org/W2033455805","https://openalex.org/W2048818094","https://openalex.org/W2051563676","https://openalex.org/W2057006907","https://openalex.org/W2077129920","https://openalex.org/W2088782204","https://openalex.org/W2101417448","https://openalex.org/W2126021594","https://openalex.org/W2137821147","https://openalex.org/W2143180984","https://openalex.org/W2150893441","https://openalex.org/W2154685498","https://openalex.org/W2167528781","https://openalex.org/W2417165560"],"related_works":["https://openalex.org/W2057006907","https://openalex.org/W7026723394","https://openalex.org/W2046671501","https://openalex.org/W2996136049","https://openalex.org/W2775103035","https://openalex.org/W2123629654","https://openalex.org/W2028031291","https://openalex.org/W2108237040","https://openalex.org/W3213702964"],"abstract_inverted_index":{"Humanized,":[0],"anti-vascular":[1],"endothelial":[2,656],"growth":[3,277,412,872],"factor":[4,413],"(VEGF)":[5],"antibodies":[6,85,189,270,301,648],"like":[7,208,313],"bevacizumab":[8],"(Avastin)":[9],"have":[10,585,776],"been":[11,429,586,611,630],"approved":[12],"by":[13,153,379,398,417,432,472,644,844],"the":[14,45,60,74,82,92,112,123,134,167,216,236,250,255,258,372,388,399,406,423,453,456,461,468,478,505,542,550,565,597,603,667,670,745,756,780,783,791,802,819,822,851,885,889],"FDA":[15,55],"for":[16,47,446,537,666,779,853],"systemic":[17],"treatment":[18,202],"in":[19,24,44,73,173,195,215,235,278,296,367,394,422,438,452,520,534,549,564,570,588,615,722,726,733,835,888],"cancer":[20],"and":[21,33,49,63,120,169,175,212,220,227,244,246,346,357,381,460,488,509,523,568,638,659,706,732,735,759,795,813,826],"local":[22],"application":[23],"age-related":[25],"macular":[26],"degeneration":[27],"[1].":[28,129,302,323,876],"In":[29,91,178,229,371,553,619,635,675,711,741],"a":[30,41,145,334,364,411,591,700,713,729,748],"recent":[31],"review":[32],"meta-analysis":[34],"of":[35,69,81,96,116,126,148,166,171,225,257,268,337,348,409,450,455,467,485,504,546,556,583,594,602,624,627,641,646,661,669,685,695,761,771,804,821,832,856,874,901],"published":[36],"clinical":[37],"trials":[38],"with":[39,190,254,271,308,385,529,572,677,699,737,837,884],"bevacizumab,":[40],"dose-dependent":[42],"increase":[43],"risk":[46],"proteinuria":[48,827],"hypertension":[50],"was":[51,76,233,305],"documented":[52,631],"[2].":[53],"The":[54,303,324,600,839,877],"therefore":[56],"issued":[57],"warnings":[58],"concerning":[59],"renal":[61,124,251,293,525,690,720,866],"toxicity":[62,252,867],"thromboembolic":[64],"events":[65],"(http://www.fda.gov/cder/drug/InfoSheets/patient/bevacizumabPIS.htm).":[66],"Preclinical":[67],"testing":[68,115,855],"anti-human":[70,83,117,155,187,857],"VEGF":[71,84,118,127,139,156,188,198,269,282,315,339,342,349,392,507,518,547,681,715,785,858,893],"agents":[72,119],"past":[75],"often":[77],"difficult,":[78],"since":[79,463],"most":[80,554,616],"failed":[86],"to":[87,143,298,319,328,596],"neutralize":[88],"rodent":[89],"VEGF-A.":[90],"27":[93],"February":[94],"issue":[95],"Proc":[97],"Natl":[98],"Acad":[99],"Sci":[100],"USA,":[101],"Gerber":[102,181,262,845],"et":[103,182,263,846],"al.":[104,183,264,847],"describe":[105],"an":[106,164,239,447,663],"improved":[107],"mouse":[108,841],"model":[109],"that":[110,266,414,865,882],"facilitates":[111],"future":[113],"preclinical":[114,854],"further":[121,592],"unravels":[122],"sequelae":[125],"inhibition":[128,873],"By":[130,512],"gene":[131],"replacement":[132],"technology,":[133],"group":[135],"engineered":[136],"mice":[137,637,676,727,734,878],"[hum-X":[138],"knock-in":[140],"(KI)":[141],"mice]":[142],"express":[144],"humanized":[146],"form":[147],"VEGF,":[149],"which":[150,317,787],"is":[151,333,363,376,415,561],"recognized":[152],"many":[154,514],"antibodies.":[157],"This":[158,403,426],"murine":[159,714],"test":[160],"system":[161,332,887],"now":[162],"allows":[163],"evaluation":[165],"efficacy":[168],"safety":[170],"VEGF-antagonists":[172],"physiological":[174],"pathophysiological":[176,321],"circumstances.":[177],"their":[179,489,510],"study,":[180],"tested":[184],"different":[185,191,521,543,777],"humanized,":[186],"VEGF-A":[192,259,325,362,375,437,451,470,486,559,584,598,628,643,701,765,797,823,886],"binding":[193,351],"affinity":[194,273,300,311,820],"healthy":[196],"hum-X":[197,281],"KI":[199,283],"mice.":[200,286],"Long-term":[201],"had":[203,289,474],"no":[204,292],"effect":[205],"on":[206,754,790],"organs":[207],"heart,":[209],"spleen,":[210],"pancreas":[211],"lung.":[213],"Changes":[214],"liver":[217],"were":[218],"subtle":[219],"included":[221],"increased":[222,562],"serum":[223],"levels":[224],"alanine-":[226],"aspartate-aminotransferase.":[228],"contrast,":[230,712],"significant":[231],"pathology":[232],"noted":[234],"kidney,":[237,374,781,890],"including":[238],"activated":[240],"mesangium,":[241,462],"damaged":[242],"endothelium":[243,401],"podocytes,":[245,589],"finally,":[247,814],"glomerulosclerosis.":[248],"Importantly,":[249],"correlated":[253],"target-affinity":[256],"antagonists.":[260,824],"Thus,":[261],"showed":[265],"administration":[267,894],"low":[272],"effectively":[274],"reduced":[275],"tumor":[276],"RAG2":[279],"knockout;":[280],"double":[284],"homozygous":[285],"However,":[287],"it":[288,892],"less":[290],"or":[291,435,649,895],"side":[294,830],"effects":[295,831],"contrast":[297],"high":[299,310],"latter":[304,442],"also":[306,862,879],"reproduced":[307],"other":[309,620,805],"antagonists":[312],"soluble":[314,341,650,686],"receptors,":[316,340,343],"led":[318],"similar":[320],"changes":[322],"(commonly":[326],"referred":[327],"as":[329,353,799,801,809,815],"\u2018VEGF\u2019":[330],"only)":[331],"complex":[335],"interplay":[336],"ligands,":[338],"e.g.":[344,763,788],"sFlt-1":[345],"modulators":[347],"receptor":[350,490],"such":[352,808],"heparan":[354],"sulphate":[355],"proteoglycans":[356],"neuropilin":[358],"receptors":[359,393,508],"(Figure":[360],"1).":[361],"key":[365],"player":[366],"(patho-)physiological":[368],"angiogenesis":[369],"[3].":[370],"normal":[373,636],"mainly":[377],"expressed":[378,397],"podocytes":[380,418,439,473],"tubular":[382],"cells":[383],"[4],":[384],"VEGF-165":[386],"being":[387],"main":[389],"isoform":[390],"[5].":[391],"turn":[395],"are":[396,498,541,828],"glomerular":[400,424,457,479,557,622,655,671,696],"[6].":[402,578],"initially":[404],"raised":[405],"puzzling":[407],"question":[408,427],"how":[410],"produced":[416],"can":[419,868],"signal":[420],"\u2018upstream\u2019":[421],"endothelium.":[425],"has":[428,607,629],"beautifully":[430],"resolved":[431],"specifically":[433],"overexpressing":[434],"deleting":[436],"[7,8].":[440,481],"These":[441],"studies":[443,515,617],"provided":[444],"evidence":[445],"important":[448,664,829],"role":[449],"maintainance":[454],"filtration":[458],"barrier":[459],"even":[464],"small":[465],"deviations":[466],"physiologic":[469],"production":[471],"detrimental":[475],"consequences":[476,778],"within":[477,747],"tuft":[480],"(A)":[482],"Schematic":[483,502],"outline":[484,503],"isoforms":[487,582,606,798],"interaction":[491],"domains.":[492],"Antagonistic":[493],"isoforms,":[494],"denoted":[495],"VEGF165b":[496],"etc.,":[497],"not":[499,610],"shown.":[500],"(B)":[501],"various":[506],"ligands.":[511],"now,":[513],"reported":[516],"dysregulated":[517],"expression":[519,560,803],"experimental":[522],"human":[524],"pathological":[526],"situations,":[527],"partly":[528],"contradictory":[530],"results":[531,540],"(extensively":[532],"reviewed":[533],"[6]).":[535],"Vital":[536],"these":[538,743],"divergent":[539],"time":[544,757],"points":[545],"analyses":[548],"respective":[551],"diseases.":[552],"instances":[555],"pathology,":[558],"early":[563,719],"disease":[566,633,750],"process":[567],"decreases":[569],"parallel":[571],"advancing":[573],"glomerulosclerosis,":[574],"i.e.":[575],"podocyte":[576],"loss":[577],"Recently,":[579],"endogenous":[580,604],"inhibitory":[581,605,796],"identified":[587],"adding":[590],"layer":[593],"complexity":[595],"system.":[599],"presence":[601],"so":[608],"far":[609],"taken":[612],"into":[613],"account":[614],"[9].":[618],"instances,":[621],"regulation":[623],"VEGF-receptors":[625],"instead":[626],"during":[632,769],"[10].":[634],"rats,":[639,725],"neutralization":[640],"circulating":[642],"injection":[645],"anti-VEGF-A":[647],"VEGF-R1":[651],"(sFlt-1)":[652,688],"induced":[653,704],"proteinuria,":[654],"cell":[657],"detachment":[658],"suppression":[660],"nephrin,":[662],"protein":[665],"maintenance":[668],"slit":[672],"diaphragm":[673],"[11,12].":[674],"progressive":[678],"crescentic":[679],"GN,":[680],"blockade":[682],"via":[683],"overexpression":[684],"VEGFR-1":[687],"accelerated":[689],"damage":[691],"[13].":[692],"Also,":[693],"prevention":[694],"capillary":[697,772],"repair":[698,773],"specific":[702,749],"aptamer":[703],"rapid":[705],"massive":[707],"tubulointerstitial":[708],"fibrosis":[709],"[14].":[710],"neutralizing":[716],"antibody":[717],"ameliorated":[718],"injury":[721],"5/6":[723],"nephrectomized":[724],"fed":[728],"high-protein":[730],"diet":[731],"rats":[736],"diabetic":[738],"nephropathy":[739],"[15\u201318].":[740],"all":[742],"cases,":[744],"outcome":[746],"entity":[751],"obviously":[752],"depended":[753],"(i)":[755],"point":[758],"duration":[760],"intervention,":[762],"blocking":[764],"after":[766],"rather":[767],"than":[768],"phases":[770],"[14]":[774],"may":[775,897],"(ii)":[782],"overall":[784],"bioactivity,":[786],"depends":[789],"ratio":[792],"between":[793],"agonistic":[794],"well":[800],"inhbitory/synergistic":[806],"factors":[807],"angiopoietin":[810],"1/2":[811],"[19]":[812],"discussed":[816],"above,":[817],"(iii)":[818],"Hypertension":[825],"anti-VEGF":[833],"therapy":[834],"patients":[836],"malignancies.":[838],"new":[840],"strain":[842],"described":[843],"[1]":[848],"markedly":[849],"improves":[850],"options":[852],"compounds.":[859],"Their":[860],"data":[861],"raise":[863],"hopes":[864],"be":[869,891,898],"separated":[870],"from":[871],"tumors":[875],"remind":[880],"us":[881],"interference":[883],"blockade,":[896],"hazardous.":[899],"Conflict":[900],"interest":[902],"statement.":[903],"None":[904],"declared.":[905]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2162633394","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
